To further assess the in vivo role of UBXN6 in the context of immunosuppression, a significant immunological feature of severe sepsis [67, 68], we established a murine model of immunosuppression via a two-hit approach involving cecal ligation and puncture (CLP) and secondary bacterial infection [69, 70]. Here, UBXN6 is linked to bacterial infectious disease.